-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0001628280-23-016426
-
accounts Payable Current
13,236,000
-
accounts Receivable Net Current
48,187,000
-
accumulated Depreciation Depletion And Amortization Property Plant And Equipment
41,373,000
-
accumulated Other Comprehensive Income Loss Net Of Tax
111,000
-
allocated Share Based Compensation Expense
10,259,000
-
assets
853,924,000
-
assets Current
489,271,000
-
cash And Cash Equivalents At Carrying Value
315,196,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
317,561,000
-
cik
1,581,280
-
common Stock Par Or Stated Value Per Share
1E-05
-
common Stock Shares Authorized
100,000,000
-
common Stock Shares Issued
57,105,000
-
common Stock Shares Outstanding
57,105,000
-
comprehensive Income Net Of Tax
--58,436,000
-
contract With Customer Liability
1,900,000
-
contract With Customer Liability Revenue Recognized
1,400,000
-
date Filed
2023-05-08
-
document Fiscal Period Focus
Q2
-
document Fiscal Year Focus
2,023
-
document Type
10-Q
-
earnings Per Share Basic
-1.04
-
earnings Per Share Diluted
-1.04
-
entity Name
Twist Bioscience Corp
-
income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
--58,480,000
-
income Tax Expense Benefit
676,000
-
interest Expense
2,000
-
inventory Net
39,923,000
-
irs Number
462,058,888
-
lessee Operating Lease Liability Payments Due
146,582,000
-
lessee Operating Lease Liability Payments Due Next Twelve Months
14,194,000
-
lessee Operating Lease Liability Payments Due Year Four
7,265,000
-
lessee Operating Lease Liability Payments Due Year Three
12,609,000
-
lessee Operating Lease Liability Payments Due Year Two
14,066,000
-
lessee Operating Lease Liability Undiscounted Excess Amount
55,362,000
-
liabilities
149,992,000
-
liabilities And Stockholders Equity
853,924,000
-
liabilities Current
72,108,000
-
net Income Loss
--59,156,000
-
operating Income Loss
--61,637,000
-
operating Lease Liability
91,220,000
-
operating Lease Liability Current
13,396,000
-
operating Lease Liability Noncurrent
77,824,000
-
operating Lease Payments
4,000,000
-
operating Lease Right Of Use Asset
70,669,000
-
other Assets Noncurrent
2,201,000
-
other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
73,000
-
other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
647,000
-
other Liabilities Current
10,040,000
-
other Liabilities Noncurrent
60,000
-
other Nonoperating Income Expense
--305,000
-
period End
1,680,220,800,000
-
period Start
1,672,531,200,000
-
property Plant And Equipment Gross
187,912,000
-
property Plant And Equipment Net
146,539,000
-
report Link
https://www.sec.gov/Archives/edgar/data/1581280/000162828023016426/twst-20230331_htm.xml
-
research And Development Expense
27,379,000
-
retained Earnings Accumulated Deficit
--929,400,000
-
selling General And Administrative Expense
53,965,000
-
stockholders Equity
703,932,000
-
trading Symbol
TWST
-
update
1970-01-01
-
weighted Average Number Of Diluted Shares Outstanding
56,777,000
-
weighted Average Number Of Shares Outstanding Basic
56,777,000
-
id
REPORTED_FINANCIALS
-
key
TWST
-
subkey
10-Q
-
date
2023-05-08
-
updated
2023-05-09
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
TWST stock fundamentals - financials as reported